AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Coniglu G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Coniak Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Coniglu G 1mg/500mg Tablet SR

Glucovance SR, a 1mg/500mg combination tablet, combats type 2 diabetes in adults. This anti-diabetic medication combines two active ingredients to regulate blood sugar. Always take it with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood glucose readings. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Commonly, Glucovance SR can cause hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Individuals with a history of heart disease should inform their doctor before use. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood sugar monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Coniglu G 1mg/500mg Tablet SR

No information provided. A rephrased version cannot be created.

Uses of Coniglu G 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Coniglu G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Coniglu G 1mg/500mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Coniglu G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Coniglu G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Coniglu G 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with food.

How Coniglu G 1mg/500mg Tablet SR works:

Coniglu G SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Coniglu G 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Coniglu G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Coniglu G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Coniglu G 1mg/500mg Tablet SR; dosage modification may be necessary. Individuals with severely compromised kidney function should avoid this medication. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Coniglu G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; however, the medication is contraindicated in those with severe liver disease.

What if you forget to take Coniglu G 1mg/500mg Tablet SR :

Should you forget a Coniglu G 1mg/500mg SR Tablet dose, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Coniglu G 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Coniglu G 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Coniglu G 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Coniglu G 1mg/500mg Tablet SR and seek immediate medical attention.
Coniglu G 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Coniglu G 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Coniglu G 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Coniglu G 1mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Coniglu G 1mg/500mg Tablet SR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Coniglu G 1mg/500mg Table...
48
MRP 55
12% off